Dogwood Therapeutics, Inc. (DWTX)

Dogwood Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.85	3.32	7.03	14.01	29.8
Cash & Short-Term Investments	14.85	3.32	7.03	14.01	29.8
Cash Growth	347.64%	-52.82%	-49.81%	-52.99%	9530.55%
Prepaid Expenses	1.7	0.71	1.18	1.35	1.59
Other Current Assets	-	0.14	0.16	0.42	0.09
Total Current Assets	16.54	4.17	8.37	15.78	31.47
Property, Plant & Equipment	0.22	-	-	-	-
Goodwill	11.81	-	-	-	-
Long-Term Deferred Charges	65.71	-	-	-	-
Other Long-Term Assets	0.02	-	-	-	-
Total Assets	94.31	4.17	8.37	15.78	31.47
Accounts Payable	1.23	0.11	0.57	0.35	0.37
Accrued Expenses	1.89	0.25	0.47	0.92	1.16
Current Portion of Leases	0.05	-	-	-	-
Total Current Liabilities	3.18	0.36	1.04	1.28	1.53
Long-Term Debt	15.38	-	-	-	-
Long-Term Leases	0.15	-	-	-	-
Long-Term Deferred Tax Liabilities	11.31	-	-	-	-
Total Liabilities	30.03	0.36	1.04	1.28	1.53
Common Stock	0	0	0	0	0
Additional Paid-In Capital	67.86	65.57	63.5	58.43	57.91
Retained Earnings	-73.82	-61.47	-56.17	-43.93	-27.97
Treasury Stock	-0.3	-0.3	-	-	-
Comprehensive Income & Other	-3.86	-	-	-	-
Total Common Equity	-10.12	3.81	7.33	14.5	29.94
Shareholders' Equity	64.28	3.81	7.33	14.5	29.94
Total Liabilities & Equity	94.31	4.17	8.37	15.78	31.47
Total Debt	15.59	-	-	-	-
Net Cash (Debt)	-0.74	3.32	7.03	14.01	29.8
Net Cash Growth	-	-52.82%	-49.81%	-52.99%	-
Net Cash Per Share	-0.72	4.42	15.88	42.04	151.18
Filing Date Shares Outstanding	1.91	0.77	0.73	0.33	0.33
Total Common Shares Outstanding	1.91	0.77	0.73	0.33	0.33
Working Capital	13.37	3.81	7.33	14.5	29.94
Book Value Per Share	-5.30	4.94	9.99	43.52	90.13
Tangible Book Value	-21.94	3.81	7.33	14.5	29.94
Tangible Book Value Per Share	-11.48	4.94	9.99	43.52	90.13

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q